|
In May 23-24, 2013 we are organizing the 2nd European Conference of National Strategies for Chlamydia trachomatis and Human Papillomavirus in Berlin.
Our committees and partners are dedicated to provide an outstanding experience for learning and scientific exchange, a tradition consistent with previous European Chlamydia and Papillomavirus conference. We are confident that our key-note speakers will spark the minds of both young as well as established researchers, epidemiologists, clinicians, health care funders, and laboratory doctors, and start valuable discussions, and enrich the Proceedings of this Symposium!
The challenge of the European health care is the recognition of Chlamydia trachomatis and Human Papillomovirus as a public health problem. Nucleic acid amplification tests are the optimal ones for the diagnosis of Chlamydia trachomatis, but are not routinely used in many countries. On-demand Human Papillomovirus vaccination provision tends to miss the lower socioeconomic groups and minorities, which are exactly the groups that are missed by the opportunistic cervical screening that still prevails in Europe.
Berlin will be at its best and will provide the perfect backdrop to our conference. All symposia and evenings will provide opportunities to help foster exchanges between members of the worldwide CT and HPV community. We invite you to come and share your knowledge in order to contribute to the advancement and use of CT and HPV technologies and to tackle the burden of CT and HPV.
We hope to see you all in the beautiful city of Berlin!
|
